INS and diabetes mellitus: The concept of adjunct therapy for type 1 diabetes has emerged in response to these challenges and is based on the notion that: (1) adding a simple (oral) preparation to insulin therapy might help to improve glycaemic control; and (2) such additional therapeutic agents might have effects independent of glucose lowering to reduce the risk of diabetes complications.